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1. Introduction
  Myocardial fibrosis (MF) often occur in the process 
of myocardial remodeling hypertensive heart disease, 
rheumatic heart disease and other diseases after myocardial 
infarction with a rising trend of fatality rate[1-3]. MF is a 
heart disease caused by collagen component change under 
increasing cardiac tissue collagen fibers due to all kinds 
of pathogenic factors[4]. Its occurrence and development 
accompanied by myocardial interstit ial  network 
reconfiguration and decreased cardiac function, can cause 
function decline of myocardial contraction and relaxation, 
seriously affecting the patients health[5]. The pathogenesis 
of MF is not entirely clear, its regulation also involves 
the renin-angiotensin aldosterone system, a variety of 
cytokines, cell apoptosis, and other systems. Studies have 
shown that[6], the oxidative stress plays an important role 
in the process of MF pathogenesis, therefore, reversal of 
MF by regulating oxidative stress is of great significance. 
Clinical treatment of anti myocardial fibrosis rely mainly 
on angiotensin-converting enzyme inhibitors (ACEI), AT1 
receptor antagonist, endothelin receptor antagonist and 毬
-blockers, of which the receptor antagonists of ACEI, AT1 
are most commonly used yet with long-term side effects, 
and these antagonists can’t completely reverse myocardial 
fibrosis process[7]. With the deepening of the motherland 
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medicine research on MF pathogenesis, great progress 
has been made in the treatment of MF. On the theory 
basis of  “cut the nut, conducting qi and blood in order 
to harmonize them” (“Plain question. To really theory”), 
ginseng mixture can promote blood circulation to remove the 
blood stasis, and activate the blood circulation. To observe 
the improvement of MF by ginseng mixture, the author 
selected Wistar rat to set up MF model treated with ginseng 
mixture lavage. The heart weight parameters, myocardial 
biochemical indexes and tissue morphology were observed 
to analyze the protection mechanism of ginseng mixture 
against MF in rats. 
2. Materias and methods
2.1. Experimental animals 
  A total of 60 clean level Wistar rats aged 2 months, male 
and female unlimited, (216.1依12.3) g, were provided by 
the Animal Experiment Center, and bred with free food 
and water at room temperature (22依1) 曟, the experimental 
process handling of animals was strictly followed by the 
regulations of experimental animals administration.
2.2. Instrument and reagent
  Automatic biochemical analyzer (Shanghai Schindler 
MedicalInstrument Company); Olympus BH- type 2 
microcope (Japan); BI-2000 immunohistochemical analysis 
system; Isopropyl adrenaline hydrochloride injection (1 mg, 
batch number: H31021344), produced by Shanghai Hefeng 
Pharmaceutical Co., LTD.; Ginseng mixture provided by the 
traditional Chinese medicine center; Captopril (12.5 mg/
tablet, batch number: H31022986) manufactured by Shanghai 
Squibb Co., LTD.; reagents including catalase (CAT), 
glutathione peroxidase (GSH-PX), hydroxyproline (Hyp), 
creatine kinase (CK), hydrogen peroxide (H2O2) and lactate 
dehydrogenase (LDH) were provided by Nanjing Institute of 
Biological Engineering. 
2.3. Modeling
  Isopropyl epinephrine injection was injected to set up the 
MF model as follows: subcutaneous injection 20.0 mg/kg for 
the first time, 10.0 mg/kg on the 2nd day, 5.0 mg/kg on the 
3rd day, 3.0 mg/kg from 4th to 10th day. During the modeling 
period, rats were provided with free access to food and 
water. Modeling criteria: each 2 rats were randomly killed 
after modeling for 10 d, myocardial tissue was extracted for 
histological observation, once the microscopic result shows 
hyperplasia of a large number of collagen fibers between the 
endocardial myocardial fibers, the MF model was regarded 
as set up. 
2.4. Grouping
  A total of 60 Wistar rats were randomly divided into control 
group without modeling operation, and another 4 groups 
had subcutaneous injections of isopropyl adrenaline for 10 d
to set up the MF model: model group with 2 mL saline 
lavage treatment after modeling for 2 d, captopril group 
with captopril lavage (0.45 mg/2 mL) after modeling for 2 d, 
ginseng mixture group A and group B with low (20 g/kg) and 
high dose (80 g/kg) mixture treatment respectively. After 
treatment for 14 d, abdominal aorta and myocardial tissue 
were extracted for observing the pathological morphological 
changes and heart weight index in each group. The lavage 
treatment were conducted for 14 consecutive d (1 time/d). 
2.5. Observation indexes
  At the end of the treatment, the rats were kept fasting for 24 
h, anesthesed using intraperitoneal injection of 3% sodium 
pentobarbital, 5 mL blood was extracted from abdominal 
aorta for observing the changes of CAT, GSH-PX, Hyp, CK, 
H2O2, LDH and other indexes, operation process were strictly 
followed by the kit manual. After the extraction of blood, 
atrium, atrial, adipose tissue and valves were eliminated 
followed by PBS washing, ventricular weight/body weight 
index was calculated according to the heart weight and body 
weight. Then the left ventricular myocardium was fixed using 
10% formalin followed by gradient ethanol dehydration, 
and embedding and sectioning using paraffin,  dyeing, 
Masson collagen fiber was HE dyed for histopathological 
observation. 
2.6. Statistical analysis 
  SPSS19.0 statistical software was used, measurement data 
were expressed with (mean 依 sd), and analyzed by t test. P< 
0.05 was regarded as significant difference. 
3. Results 
3.1. Comparison between groups in the rat heart weight index
  The left ventricular mass index and ventricular weight/
body weight index of model group, captopril group and 
groups A and B were significantly higher than that of control 
group (P<0.05);  left ventricular mass index and ventricular 
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weight/body weight index of captopril group and group B 
were significantly lower than that of model group and group 
A (P<0.05), left ventricular mass index of captopril group was 
the minimum among all the group (Table 1). 
Table 1
Comparison between groups in the rat heart weight index (mg/g).
Group n
left ventricular mass 
index
ventricular weight/
body weight index
Control group 10 2.23依0.11 3.09依0.21
Model group 10 3.38依0.15 4.45依0.21
Captopril group 10 2.96依0.15 3.74依0.17
Group A 10 3.37依0.16 4.20依0.26
Group B 10 3.10依0.13 3.79依0.13
3.2.  Hyp level and CAT activity in myocardial tissue of each 
group
  Model group and ginseng group A showed higher Hyp 
content and  lower CAT activity in myocardial tissue 
compared with control group (P<0.05). The captopril group 
and group B showed lower Hyp content and higher CAT 
activity compared with model group and group A (P<0.05). 
There was no significant difference in Hyp content and CAT 
activity between captopril group, group B and the control 
group (P>0.05) (Table 2). 
Table 2
Comparision of Hyp level and CAT activity in myocardial tissue 
between groups.
Group n Hyp level (mg/g.prot) CAT activity(U/mg.prot)
Control group 10 0.36依0.11 6.72依0.89
Model group 10 0.48依0.13 4.70依1.06
Captopril group 10 0.33依0.09 6.28依1.25
Group A 10 0.43依0.06 5.70依0.91
Group B 10 0.37依0.05 6.14依1.21
3.3. Serum GSH-PX, CAT, CK and LDH activity and H2O2 
content between groups
  Model group and group A showed a significantly lower 
serum GSH-PX, CAT activity and a higher CK, LDH and 
H2O2 content than the control group (P<0.05). There was no 
significant difference in f GSH-PX, CAT, LDH activity and 
H2O2 content between captopril group and group B (P>0.05) 
(Table 3).
3.4. Myocardial tissue morphology observation 
  Microscopic observation showed control group with normal 
myocardial fibers, round or oval myocardial nuclei, and a 
small number of collagen fibers between myocardial tissue 
could be observed with occasional inflammatory cells. 
In model group, collagen fiber hyperplasia, vasodilation 
congestion with inflammatory cells infiltration were 
visible between myocardial fibers; the group A showed 
more collagen fiber hyperplasia, but without angiectasis 
hyperemia; the captopril group and group B showed a 
small number of collagen fibers in heart periosteal tissue 
microscopically (Figure 1, 2). 
            
 Control group                          Model group                            Captopril group
Group A                                                    Group B
Figure 1.  Morphology observation of myocardial tissue (HE, ×200). 
   Control group                             Model group                           Captopril group 
 Group A                                              Group B
Figure 2.  Morphology observation of myocardial t issue 
(Massom×400). 
Table 3
Serum GSH-PX, CAT, CK and LDH activity and H2O2 content between groups.
Group n GSH-PX(U) CAT (U/mL) CK (U/mL) LDH (U/L) H2O2 (mmol/L)
Control group 10 176.806依15.586 10.99依1.24   36.83依6.79 5059.60依344.88 26.610依5.013
Model group 10 132.530依22.935   8.22依1.65   136.64依16.28 6304.50依488.51 36.209依3.615
Captopril group 10 161.683依16.241 10.00依1.14   110.79依10.55 5127.60依315.52 27.499依5.008
Group A 10 147.014依15.501   9.53依0.93 103.85依5.01 5338.47依316.75 33.495依7.590
Group B 10 160.503依14.548 10.13依1.23     86.52依16.31 5834.90依395.81 27.812依5.820
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4. Discussion 
  Myocardial tissue, which mainly consists of myocardial 
cells and collagen secreted by normal myocardial fibroblasts 
form a fiber network connection, which plays an important 
role in maintaining cardiac structure and function[8-12]. As 
pathogenic factors induce MF occurs, excessive activation 
and proliferation of myocardial fibroblasts can lead to 
extracellular matrix deposition, myocardial stiffness, and 
electrophysiological disorders[13]. In addition, increased 
concentration of myocardial interstitial collagen reduces 
capillary density, limits the oxygen diffusion between 
myocardial cells, increases myocardial ischemia, forming a 
vicious cycle, which eventually leads to refractory congestive 
heart failure, so the MF is a necessary procedure to end-
stage heart disease[14]. Therefore, to prevent or reverse MF 
is of great significance to patients’ health. Establishment 
methods commonly used for MF model in rats are: 
subcutaneously injection of catecholamine in abdomen aorta 
and coronary ligation method and subcutaneous injection 
of high-dose isopropyl adrenaline method[15-17]. The author 
established Wistar rats MF model by using subcutaneous 
injection of high-dose isopropyl adrenaline, and two rats of 
each group were randomly selected and executed after 10 d 
of modeling, microscopic observation of myocardial tissue 
showed a large number of collagen fibers, indicating that 
this method to establish the rat MF model is effective. 
  There is no explicitly specify of MF in Chinese trandition 
medicine. MF is generally belong to the “bi”, “palpitation”, 
“edema” because of its main symptoms of chest pain, 
chest condition, palpitations, shortness of breath, breathing 
difficulties, and so on[18]. MF pathogenesis is associated with 
lung, liver, spleen and kidney, mainly on the heart arteries 
and veins. Therefore, appropriate treatment should replenish 
blood and qi. Based on the “plain question. To really 
theory” main ingredients of ginseng mixture include: salvia 
miltiorrhiza, radix astragali, radix paeoniae rubra, angelica, 
peach kernel, safflower, earthworm, leeches, pinellia, etc. 
By promoting blood circulation to remove blood stasis as the 
therapeutic principles. 
  Salvia miltiorrhiza activates the circulation of bloodstream. 
Astragalus membranaceus can greatly tonify the spleen and 
stomach, quickly removes the blood stasis. Radix paeoniae 
rubra can promote blood circulation; Angelica invigorates 
the circulation of blood and blood stasis without harming 
body; Rhizoma ligustici wallichii invigorates good blood 
and qi; Peach kernel, safflower, have strong effect of huoxue 
quyu, the auxiliary medicine salvia miltiorrhiza can enhance 
the main medicine. Lumbricus can only strengthen body 
fluid and remove the adverse effect of blood stasis. 
  Studies have confirmed that[19], Hyp content in myocardial 
tissue can be used as an important index of judging the 
degree of myocardial fibrosis. In addition, HW/BW, and 
left ventricular weight (LVW)/BW ratio were positively 
associated with the degree of myocardial fibrosis, also serve 
as important indexes of judging the degree of myocardial 
fibrosis[20]. In this experiment, the model group showed 
significantly higher level of HW/BW, LVW/BW and Hyp 
in the myocardial tissue compared with control group; the 
reduced HW/BW, LVW/BW and Hyp of captopril group and 
group B suggest that the mixture can inhibit myocardial 
interstitial collagen formation and relieve the myocardial 
fibrosis. In MF occurrence and development process, a 
large number of oxygen free radicals can be produced 
during generating H2O2 in a short period of time, leading 
to excessive consumption of GSH-PX and CAT, so the 
abnormal changes of H2O2 content can also reflect the 
myocardial cell damage degree in process of MF, and the 
CAT and GSH-PX content changes, also can reflect the 
body’s ability to remove reactive oxygen species[21-23]. 
  In this study, the serum H2O2 content of model group rats 
increased significantly, showed that myocardial cell was 
greatly damaged; Activity of GSH-PX and CAT at the same 
time, suggest ability to remove reactive oxygen species H2O2 
by GSH-PX and CAT decreased severely; The captopril 
group and group B can improve the activity of GSH-PX 
and CAT, increase H2O2 clearance. The experiment results 
showed that ginseng mixture in high dose with significant 
effect, no statistical difference was observed compared 
with captopril group (P>0.05). It indicates that ginseng 
mixture can raise the activity of GSH-PX and CAT, reduce 
lipid peroxidation damage by H2O2, improve cell normal 
function, so as to achieve resisting myocardial fibrosis[24,25]. 
According to histopathology study, endocardial collagen 
fiber hyperplasia of model group was serious, combined with 
small amount of inflamatory cells infiltration; only a small 
amount of collagen fibers were observed in group B, with 
occasional inflammatory cells infiltration. It indicates that 
a certain dose of ginseng mixture can inhibit myocardial 
collagen from secretion for MF rat, thus inhibiting the 
occurrence and development of MF. 
  This experiment shows that ginseng mixture is a effective 
drug for treatment of MF by inhibiting antioxidant effect 
during myocardial fibrosis process, which reflects not 
only the traditional Chinese medicine yiqi huoxue therapy 
principles of MF, but also the guidelines of modern medical 
treatment. 
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